BCIQ Profiles

Company Profile ReportTarget Profile Report

Antisense-mediated exon skipping for X-linked Alport syndrome

DISEASE CATEGORY: Renal

INDICATION: Renal

Exon skipping therapy with an antisense oligonucleotide (ASO) targeting a truncating variant

Read the full 156 word article

How to gain access

Continue reading with a
two-week free trial.